← Insider buys
ADAP

Adaptimmune Therapeutics Plc · HEALTHCARE

Director Ali Behbahani bought $20.0M of Adaptimmune Therapeutics Plc

Bought$20,000,400
$1.67Price
12,000,000Shares

What ADAP did for a copier

Prices for ADAP after this filing aren't in yet.

Ali Behbahani's record

5 other buys with 3 months of prices since 2019: on average −10.1% against the S&P 500, and 2 of 5 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Fri, Sep 7. Filed Mon, Sep 10, 4:47 PM ET, after the close. Not investment advice.